Skip to content

Welcome to Discover Pharma! Today is : October 16, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Gene Therapy

  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Therapeutic Areas

    Ascidian boosts RNA therapy push with key hire and expert board for Stargardt trial

    Ascidian Therapeutics has appointed Murray Abramson as chief development officer. [...]

    May 5, 2026
  • Opinion & Events

    CureDuchenne appoints Dr Brenda Wong as chief medical advisor

    Renowned neuromuscular clinician and researcher to shape care strategies and [...]

    May 5, 2026
  • Advanced Therapies

    Cherwell introduces Redipor TwistLock plate range to aid microbial environmental monitoring

    Cleanroom microbiology expert Cherwell, an Analytichem company, has launched a [...]

    May 5, 2026
  • Biotech & Pharma Business,Manufacturing & Supply Chain

    Chrysalis launches following cleanroom asset acquisition and strategic investment

    Chrysalis, a GMP-compliant space and service provider, has formally launched [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Manufacturing & Supply Chain

    SpliceBio secures $135 Million series B to advance dual-AAV therapy for Stargardt Disease

    Funding will support clinical development of SB-007 and expand pipeline [...]

    May 5, 2026
  • Advanced Therapies,Drug Delivery & Formulation

    N4 Pharma reports positive in vivo results from oral IBD gene therapy study using Nuvec

    UK-based biotech N4 Pharma has announced encouraging in vivo results [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development

    Limula secures US patent for automated cell therapy manufacturing tech

    Limula has confirmed the granting of a core patent in [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development

    CureDuchenne backs Entos in bid to deliver full-length, redosable dystrophin gene therapy

    A new partnership aims to change the game in gene [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Manufacturing & Supply Chain,Opinion & Events

    ScaleReady awards multiple G-Rex grants to USC and Children’s Hospital of Los Angeles Investigators

    ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation, and [...]

    May 5, 2026
  • Advanced Therapies

    GeneFab and RegCell partner to advance autoimmune Treg therapy toward US trials

    May 5, 2026
Previous567Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Nabsys EGM detects genomic abnormalities in five-sample leukemia study
    Categories: Genomics and sequencing, Research & Development, Therapeutic Areas
  • Calibre secures CQC registration for nationwide AI health service
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Digital & Data, Pharmaceuticals and therapeutics, Research & Development
  • Cyllene gene therapy for bladder disorder gains FDA RMAT designation
    Categories: Drug Discovery & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top